These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9175807)

  • 1. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients.
    Chan C; Maurer J; Cardella C; Cattran D; Pei Y
    Transplantation; 1997 May; 63(10):1435-40. PubMed ID: 9175807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.
    Mourad G; Vela C; Ribstein J; Mimran A
    Transplantation; 1998 Mar; 65(5):661-7. PubMed ID: 9521200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
    Koller-Strametz J; Wolzt M; Fuchs C; Putz D; Wisser W; Mensik C; Eichler HG; Laufer G; Schmetterer L
    Kidney Int; 1999 May; 55(5):1871-7. PubMed ID: 10231449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients.
    Hansen JM; Christensen NJ; Fogh-Andersen N; Strandgaard S
    Nephrol Dial Transplant; 1996 Feb; 11(2):340-6. PubMed ID: 8671790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing.
    Bunke M; Sloan R; Brier M; Ganzel B
    Transplantation; 1995 Feb; 59(4):537-40. PubMed ID: 7878758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP; Natov S; Boitard C; Lacour B; Grünfeld JP
    Nephrol Dial Transplant; 1996 Apr; 11(4):673-8. PubMed ID: 8671857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial.
    Frantz RP; Edwards BS; Olson LJ; Schwab MK; Adams TF; Textor SC; Daly RC; McGregor CG; Rodeheffer RJ
    Transplantation; 1997 Jun; 63(11):1607-10. PubMed ID: 9197354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
    Rodicio JL
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S7-11. PubMed ID: 11347860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine-induced renal dysfunction in experimental animals and humans.
    Remuzzi G; Perico N
    Kidney Int Suppl; 1995 Dec; 52():S70-4. PubMed ID: 8587288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
    Gossmann J; Radounikli A; Bernemann A; Schellinski O; Raab HP; Bickeböller R; Scheuermann EH
    Kidney Blood Press Res; 2001; 24(2):111-5. PubMed ID: 11435743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1996 Jan; 11(1):153-8. PubMed ID: 8649625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function in cyclosporine-treated pediatric renal transplant recipients in relation to gingival overgrowth.
    Wondimu B; Berg U; Modéer T
    Transplantation; 1997 Jul; 64(1):92-6. PubMed ID: 9233707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of verapamil on cyclosporine. A (CsA)-induced nephropathy in ischemic kidney model in rats: changes in systemic hemodynamics and hepatic and renal microsomal cytochrome P-450].
    Kishimoto T; Tsujino T; Nakatani T; Kim T; Ohyama A; Yoshimura R; Sakamoto W; Maekawa T; Kawashima H; Kusunose E
    Hinyokika Kiyo; 1991 Oct; 37(10):1159-64. PubMed ID: 1755405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
    Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction.
    Pollak R; Knight R; Mozes MF; Maddux M; Veremis S; Van Buren C; Lewis R; Scott E; Cole M; Hyndman V
    Am J Kidney Dis; 1992 Oct; 20(4):336-41. PubMed ID: 1415200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.